Join CancerNetwork’s Prostate Cancer Tweet Chat

Article

CancerNetwork® will be hosting a tweet chat that will feature mock tumor board on prostate cancer this Friday, October 30th, at 12 PM EST.

Join CancerNetwork® on Twitter this Friday, October 30th, at 12 PM EST for a tweet chat on prostate cancer.

This mock tumor board will discuss real patient cases and present various treatment options for review, with guest commentary on each case offered from experts in the field.

Led by Judd W. Moul, MD, FACS, a urologic oncologist at Duke Cancer Center and Duke Urology Clinic, the chat will feature guest commentary from Daniel Spratt, MD, chief of the Genitourinary Radiotherapy Program, associate chair of Clinical Research, and the Laurie Snow Endowed Research Professor at the Rogel Cancer Center of the University of Michigan, Alicia K. Morgans, MD, MPH, associate professor of Medicine at the Robert H. Lurie Comprehensive Cancer Center of the Northwestern University Feinberg School of Medicine, and Stacy Loeb, MD, MSc, PhD (hon.), professor of Urology and Population Health at NYU Langone Health and the Manhattan Veterans Affairs.

To participate in the chat, just follow the directions below.

prostate cancer tweet chat how to

Recent Videos
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
An 80% sensitivity for lung cancer was observed with the liquid biopsy, with high sensitivity observed for early-stage disease, as well.
9 Experts are featured in this series.
9 Experts are featured in this series.
Harmonizing protocols across the health care system may bolster the feasibility of giving bispecifics to those with lymphoma in a community setting.
2 experts are featured in this series.
Patients who face smoking stigma, perceive a lack of insurance, or have other low-dose CT related concerns may benefit from blood testing for lung cancer.
9 Experts are featured in this series.
Related Content